期刊论文

Mechanism of Traditional Chinese Medicine Compound in Preventing and Treating Hepatocellular Carcinoma

中文

中国实验方剂学杂志

1005-9903

2019

25

24

196-204

10.13422/j.cnki.syfjx.20191921

湖南省科技计划项目(2016SK2033) 长沙市科技局计划项目(kp1801043) 湖南省中医药管理局重点项目(201614) 湖南中医药大学中药学一流学科(校行科字[2018]3号) 湖南中医药大学中药学一流学科开放基金项目(2018ZYX02) 湖南省教育厅项目(14C0861)。

本校为第一机构

肝细胞癌是世界上最常见的恶性肿瘤。尽管肝癌在诊断和治疗方面取得了一些进展,但由于不易被早期诊断并且病情进程快,仍然是全球癌症死亡的第三大原因。中国亦是肝癌的高发地区,发病人数较多且呈上升趋势,防治形势相当严峻。目前,西医对于肝癌复杂发病机制与临床治疗思路尚不清晰,仍然存在许多短板并面临着巨大的挑战,而中医药在治疗肝癌方面具有其独特的优势,讲究整体观念,对于肝癌的治疗功效独特、副作用相对较小;不仅可以抑制肿瘤生长,还能改善患者的临床症状并提高其生存质量。因此,中医药方剂治疗肝癌的研究吸引了无数临床工作者和科研学者们的目光。但是中药复方的化学成分复杂,作用靶点多...

Hepatocellular carcinoma(HCC) is the most common malignancy in the world. Although there is progress in HCC diagnosis and treatment, it is still the third leading cause of cancer death worldwide because it is not easily diagnosed early and the disease progresses quickly. China is a high-risk area for HCC, and the number of cases is high and on the rise. Its prevention and treatment is a pressing problem. At present, western medicine is still unclear about the complex pathogenesis and clinical treatment of HCC. There are still many shortcomings and huge challenges. Traditional Chinese medicine(...